Ontology highlight
ABSTRACT:
SUBMITTER: Juzeniene A
PROVIDER: S-EPMC7918517 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
Juzeniene Asta A Stenberg Vilde Yuli VY Bruland Øyvind Sverre ØS Larsen Roy Hartvig RH
Cancers 20210213 4
Bone, lymph node, and visceral metastases are frequent in castrate-resistant prostate cancer patients. Since such patients have only a few months' survival benefit from standard therapies, there is an urgent need for new personalized therapies. The prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer and is a molecular target for imaging diagnostics and targeted radionuclide therapy (theragnostics). PSMA-targeted α therapies (PSMA-TAT) may deliver potent and local radiat ...[more]